openPR Logo
Press release

Regenerative Medicine Market worth $40.6 billion by 2027 - Leading Key Players are Novartis AG (Switzerland), Biogen (US), Sarepta Therapeutics, Inc. (US), Gilead Sciences, Inc. (US), Amgen, Inc. (US), Smith & Nephew plc (UK)

01-16-2023 08:39 AM CET | Health & Medicine

Press release from: MarketsandMakets

Regenerative Medicine Market worth $40.6 billion by 2027

Regenerative Medicine Market worth $40.6 billion by 2027

Regenerative Medicine Market is projected to reach USD 40.6 billion by 2027 from USD 12.2 billion in 2022, at a CAGR of 27.2% according to a new report by MarketsandMarkets™. The major factors driving the growth of the regenerative medicine market are the availability of funding and rising investments in R&D, increasing clinical trials for stem cells and CAR-T cell therapies, and rising advancements in tissue engineered products.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=65442579&utm_source=OPenpr&utm_medium=referral&utm_campaign=paidpr

Browse in-depth TOC on "Regenerative Medicine Market"
193 - Tables
49 - Figures
192 - Pages

Cell therapy segment accounted for the largest share of the regenerative medicine market

Based on the product, the regenerative medicine market is segmented into musculoskeletal disorders, oncology, dermatology & wound care, ophthalmology, cardiovascular diseases, and other applications. In 2021, the musculoskeletal disorders segment accounted for the largest share of the global regenerative medicine market. Growth in this market segment can be attributed to the rising research on musculoskeletal regeneration and prevalence of orthopedic disorders.

Musculoskeletal disorder is the largest-growing application segment of the regenerative medicine market

Based on application, the regenerative medicine market is segmented into academic & research institutes, contract research organizations (CROs), and pharmaceutical & biotechnology companies. In 2021, the academic & research institutes segment accounted for the largest share of the regenerative medicine market. Market growth can largely be attributed to the increase in research intensity in this end-user segment and the availability of sufficient grants and funds for research.

North America accounted for the largest share of the regenerative medicine market

North America held the largest share in the global market, followed by Europe. The large share of the North American regional segment can be attributed to the increase in research targeted toward developing cell-based therapies in the past decade and increasing research activities in regenerative medicine and growing awareness of personalized medicine have also resulted in the establishment of stem cell banking and tissue engineering.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=65442579&utm_source=OPenpr&utm_medium=referral&utm_campaign=paidpr

Regenerative Medicine Market Dynamics:

Drivers:

Rising prevalence of chronic diseases, genetic disorders, and cancer
Rising investments in regenerative medicine research
Growing pipeline of regenerative medicine products

Restraints:

Ethical concerns related to the use of embryonic stem cells in research & development
High cost of cell and gene therapies

Opportunities:

Implementation of the 21st Century Cures Act
Rising demand for organ transplantations
Key Market Players:

The regenerative medicine market is consolidated in nature with prominent players in the regenerative medicine market include Novartis AG (Switzerland), Biogen (US), Sarepta Therapeutics, Inc. (US), Gilead Sciences, Inc. (US), Amgen, Inc. (US), Smith & Nephew plc (UK), Medipost Co., Ltd. (South Korea), JCR Pharmaceuticals Co., Ltd (Japan), Takeda Pharmaceutical Company (Japan), CORESTEM, Inc (South Korea), Vericel Corporation (US), MIMEDX (US), Organogenesis Inc. (US), Medtronic plc (US), Orthocell Ltd. (Australia), Mesoblast Ltd (Australia), BioRestorative Therapies, Inc (US), Pluri Inc. (Israel), Tegoscience (South Korea), Anterogen Co., Ltd. (South Korea), bluebird bio, Inc. (US), APAC Biotech (India), Shenzhen SiBiono Genetech Co., Ltd. (China), Aspect Biosystems (Canada), and Athersys, Inc. (US).

Recent Developments:

In 2022, Novartis announces collaboration with Alnylam to explore targeted therapy to restore liver function.

In 2020, AbbVie acquired Allergan to enhance its product portfolio in immunology, hematologic oncology, neuroscience, and Allergan aesthetics.

In 2022, MiMedx announced the launch of Axiofill, an Extracellular Matrix (ECM) Particulate product derived from human placental tissue. Axiofill is a human placental-derived particulate product available for surgical recovery procedures.

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=65442579&utm_source=OPenpr&utm_medium=referral&utm_campaign=paidpr

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/regenerative-medicine-market.asp
Visit Our Website: https://www.marketsandmarkets.com/
Content Source: https://www.marketsandmarkets.com/PressReleases/regenerative-medicine.asp

About MarketsandMarkets™:

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Regenerative Medicine Market worth $40.6 billion by 2027 - Leading Key Players are Novartis AG (Switzerland), Biogen (US), Sarepta Therapeutics, Inc. (US), Gilead Sciences, Inc. (US), Amgen, Inc. (US), Smith & Nephew plc (UK) here

News-ID: 2883793 • Views:

More Releases from MarketsandMakets

Wire & Cable Market worth $266.2 billion by 2029
Wire & Cable Market worth $266.2 billion by 2029
The report "Wire & Cable Market by Product Type (Electronic Wire, Power Cable, Control & Instrumentation Cable, Communication Cable, Flexible & Specialty Cable), Material Type, Voltage, Installation, End-Use Industry, and Region - Global Forecast to 2029", wire & cable market is estimated at USD 201.0 billion in 2024 and is projected to reach USD 266.2 billion by 2029, at a CAGR of 5.8% from 2024 to 2029. Browse in-depth TOC on
Future of Healthcare Biometrics Market: Development, Industry Size, Key Players, and Forecast to 2028
Future of Healthcare Biometrics Market: Development, Industry Size, Key Players, …
Biometrics as a Service in Healthcare Market in terms of revenue was estimated to be worth $0.4 billion in 2023 and is poised to reach $1.1 billion by 2028, growing at a CAGR of 20.7% from 2023 to 2028 according to a new report by MarketsandMarkets™. The amalgamation of biometric data with cutting-edge analytics and artificial intelligence (AI) has emerged as a transformative force within the healthcare sector, significantly bolstering market
Clinical Communication & Collaboration Market Worth $4.8 billion | MarketsandMarkets™
Clinical Communication & Collaboration Market Worth $4.8 billion | MarketsandMar …
Clinical Communication & Collaboration Market in terms of revenue was estimated to be worth $2.6 billion in 2024 and is poised to reach $4.8 billion by 2029, growing at a CAGR of 13.2% from 2024 to 2029 according to a new report by MarketsandMarkets™. The growth in the clinical communication and collaboration market is driven by high prevalence of chronic diseases, rising prominence of big data and mHelath tools, and stringent
Exploring Market Surge: Impact of Booming Computer Vision Healthcare Market on Industries by 2029
Exploring Market Surge: Impact of Booming Computer Vision Healthcare Market on I …
Computer Vision in Healthcare Market in terms of revenue was estimated to be worth $3.9 billion in 2024 and is poised to reach $11.5 billion by 2029, growing at a CAGR of 24.0% from 2024 to 2029 according to a new report by MarketsandMarkets™. The market's expansion is fueled by the exponential growth of medical imaging data which necessitates efficient analysis methods, where computer vision techniques excel in automating and enhancing

All 5 Releases


More Releases for Regenerative

Regenerative Tourism & Nature Retreats Market May See a Big Move | Major Giants …
HTF MI just released the Global Regenerative Tourism & Nature Retreats Market Study, a comprehensive analysis of the market that spans more than 143+ pages and describes the product and industry scope as well as the market prognosis and status for 2025-2032. The marketization process is being accelerated by the market study's segmentation by important regions. The market is currently expanding its reach. Key Players in This Report Include: Intrepid Travel, Regenerative
Regenerative Travel Hospitality Market Is Booming Worldwide | Major Giants Six S …
HTF MI recently introduced Global Regenerative Travel Hospitality Market study with 143+ pages in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status (2025-2033). The market Study is segmented by key regions which is accelerating the marketization. At present, the market is developing its presence. Major companies in Regenerative Travel Hospitality Market are: Six Senses Regenerative, Soneva Regeneration, Wilderness Safaris, The Brando Regenerative, Aman Eco-Restoration, Banyan
Recognizing Leadership in Regenerative Care
Medical Tech Outlook is turning the focus to the companies that are innovating healthcare, particularly in regenerative medicine, in the Asia-Pacific region. HELENE Clinic has been honored by Medical Tech Outlook as the Top Regenerative Medicine Solution Provider in APAC 2025(https://www.medicaltechoutlookapac.com/helene-clinic). This accolade highlights the company's commitment to responsible innovation and its expertise in transforming regenerative scientific advancements into practical, patient-centered healthcare solutions. Why is regenerative medicine gaining importance in today's healthcare
Regenerative Aesthetics Exosome Products Market Analysis Reveals Growing Consume …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Regenerative Aesthetics Exosome Products Market- (Application (Skin Rejuvenation, Hair Restoration, Scar Reduction and Wound Healing, Anti-Inflammatory Treatments), End User (Aesthetic Clinics, Home Use, Dermatology Clinics)), By Region, Trends, Industry Competition Analysis, Revenue and Forecast To 2034." According to the latest research by InsightAce Analytic, the Global Regenerative Aesthetics Exosome Products Market is expected to grow with
Regenerative Medicine Market - Unlocking the Body's Regenerative Capacity: Redef …
Newark, New Castle, USA: The "Regenerative Medicine Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Regenerative Medicine Market: https://www.growthplusreports.com/report/regenerative-medicine-market/7671 This latest report researches the industry structure, sales, revenue,
Regenerative Medicine Market - Embrace the Future of Healing: Redefining Care wi …
Newark, New Castle, USA - new report, titled Regenerative Medicine Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Regenerative Medicine market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Regenerative Medicine market. The report offers an overview of the market, which